Device-Based Therapy for Resistant Hypertension : An Up-to-Date Review
© 2022. Italian Society of Hypertension..
Hypertension is the major risk factor for cardiovascular morbidity and mortality. Matter of fact, untreated hypertension can worsen the overall health, whereas pharmacotherapy can play an important role in lowering the risk of high blood pressure in hypertensive patients. However, persistent uncontrolled hypertension remains an unsolved condition characterized by non-adherence to medication and increased sympathetic activity. This paper will review the non-pharmacological treatments for resistant hypertension (RH) that have emerged in recent years. In addition, the technologies developed in device-based RH therapy, as well as the clinical trials that support their use, will be discussed. Indeed, the novel device-based approaches that target RH present a promising therapy which has been supported by several studies and clinical trials, whereas drug non-adherence and high sympathetic activity are known to be the main causes of RH. Nevertheless, some additional aspects of these RH systems need to be tested in the near future, with a particular focus on the device's design and availability of randomized controlled trials.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension - 29(2022), 6 vom: 21. Nov., Seite 537-546 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jami, Oussama [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antihypertensive Agents |
|---|
| Anmerkungen: |
Date Completed 01.12.2022 Date Revised 01.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s40292-022-00539-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346940060 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346940060 | ||
| 003 | DE-627 | ||
| 005 | 20231226032641.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40292-022-00539-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1156.xml |
| 035 | |a (DE-627)NLM346940060 | ||
| 035 | |a (NLM)36178479 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jami, Oussama |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Device-Based Therapy for Resistant Hypertension |b An Up-to-Date Review |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.12.2022 | ||
| 500 | |a Date Revised 01.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. Italian Society of Hypertension. | ||
| 520 | |a Hypertension is the major risk factor for cardiovascular morbidity and mortality. Matter of fact, untreated hypertension can worsen the overall health, whereas pharmacotherapy can play an important role in lowering the risk of high blood pressure in hypertensive patients. However, persistent uncontrolled hypertension remains an unsolved condition characterized by non-adherence to medication and increased sympathetic activity. This paper will review the non-pharmacological treatments for resistant hypertension (RH) that have emerged in recent years. In addition, the technologies developed in device-based RH therapy, as well as the clinical trials that support their use, will be discussed. Indeed, the novel device-based approaches that target RH present a promising therapy which has been supported by several studies and clinical trials, whereas drug non-adherence and high sympathetic activity are known to be the main causes of RH. Nevertheless, some additional aspects of these RH systems need to be tested in the near future, with a particular focus on the device's design and availability of randomized controlled trials | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Clinical trials | |
| 650 | 4 | |a Device-based therapy | |
| 650 | 4 | |a Non-invasiveness | |
| 650 | 4 | |a Resistant hypertension | |
| 650 | 4 | |a Sympathetic nerve activity | |
| 650 | 7 | |a Antihypertensive Agents |2 NLM | |
| 700 | 1 | |a Tijani, Youssef |e verfasserin |4 aut | |
| 700 | 1 | |a Et-Tahir, Aziz |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension |d 1997 |g 29(2022), 6 vom: 21. Nov., Seite 537-546 |w (DE-627)NLM09364731X |x 1179-1985 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2022 |g number:6 |g day:21 |g month:11 |g pages:537-546 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40292-022-00539-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2022 |e 6 |b 21 |c 11 |h 537-546 | ||